Joseph Manhede
CIK: 0002144095
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RCKT
ROCKET PHARMACEUTICALS, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Manhede Joseph
Manhede Joseph (SEC CIK 0002144095) files insider reports with the SEC as Principal Accounting Officer of ROCKET PHARMACEUTICALS, INC. (RCKT).
Signal8 holds 1 ownership filing by Manhede Joseph, a Form 3, filed on Jul 8, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Manhede Joseph's filings is in CRANBURY, NJ.
Other insiders filing for ROCKET PHARMACEUTICALS, INC. (RCKT)
- Wilson Martin, General Counsel
- Shah Gaurav, CEO
- Stevens Christopher James, Chief Operating Officer
- Chaudhuri Sarbani
- SOUTHWELL DAVID P, Director
- WONG RODERICK, Director